Treatment of cardiovascular disease may be more effective in the future due to a new scientific discovery.
Research which was presented at the American Heart Association Scientific
Sessions 2011 found a new drug has the potential to lower cholesterol levels.
The trial of the drug, called evacetrapib, was conducted on people with high
levels of LDL cholesterol and low amounts of HDL cholesterol – the ratio most
likely to lead to the development of cardiovascular disease.
"This study indicates that evacetrapib may potentially have some effect
on helping to lower bad cholesterol and improve good cholesterol levels in the
blood," the British Heart Foundation's senior cardiac nurse Natasha
Stewart said.
She also advised the use of statins to help lower levels of cholesterol in
the blood.
According to the charity, as well as high cholesterol, the risk of a person
developing cardiovascular disease increases if they smoke, have high blood
pressure and are overweight.
© Adfero Ltd
Heart treatment news : 20 November 2011
